A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Moxifloxacin Impurity W | Moxifloxacin Impurity W. Uses: For analytical and research use. Group: Impurity standards. CAS No. 442882-27-1. Molecular Formula: C15H12N2O3. Mole Weight: 268.27. Catalog: APB442882271. |  |
| Moxifloxacin Impurity Y | Moxifloxacin Impurity Y. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2445515-66-0. Molecular Formula: C21H25N3O5. Mole Weight: 399.45. Catalog: APB2445515660. | |
| Moxifloxacin Impurity Z | Moxifloxacin Impurity Z. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-cyclopropyl-6,7-difluoro-8-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. CAS No. 154093-72-8. Molecular Formula: C13H9F2NO4. Mole Weight: 281.21. Catalog: APB154093728. | |
| Moxifloxacin N-sulfate | An impurity of Moxifloxacin, which is fourth generation antibacterial agent. Synonyms: 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-1-sulfo-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Disodium Salt. Grades: > 95%. CAS No. 234080-64-9. Molecular formula: C21H24FN3O7S. Mole weight: 481.5. |  |
| Moxifloxacin N-Sulfate Disodium Salt | A sulfometabolite of Moxifloxacin. Group: Biochemicals. Alternative Names: 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-1-sulfo-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Disodium Salt. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. |  Worldwide |
| Moxifloxacin Related Compound A (HCl salt form) | An impurity of Moxifloxacin. Moxifloxacin is an antibiotic used to treat bacterial infenctions such as community acquired pneumonia, complicated skin infections and complicated intra-abdominal infections. Grades: 95%. CAS No. 151282-23-4. Molecular formula: C20H22ClF2N3O3. Mole weight: 425.863. | |
| Moxifloxacin Related Impurity 1 | An impurity of Moxifloxacin, which is fourth generation antibacterial agent. Synonyms: trans-2,8-Diazabicyclo[4.3.0]nonane; (4aR,7aS)-rel-Octahydro-1H-pyrrolo[3,4-b]pyridine; trans-octahydro-1H-Pyrrolo[3,4-b]pyridine; Moxifloxacin Impurity. Grades: > 95%. CAS No. 158060-81-2. Molecular formula: C7H14N2. Mole weight: 126.2. | |
| Moxifloxacin Related Impurity 2 | An impurity of Moxifloxacin, which is fourth generation antibacterial agent. Synonyms: (1R,6S)-2,8-Diazabicyclo[4.3.0]nonane; (4aS-trans)-Octahydro-1H-pyrrolo[3,4-b]pyridine; Moxifloxacin Impurity 2. Grades: > 95%. CAS No. 169533-56-6. Molecular formula: C7H14N2. Mole weight: 126.2. | |
| Moxifloxacin Related Impurity 3 | An impurity of Moxifloxacin, which is fourth generation antibacterial agent. Synonyms: 7-(3a-aminohexahydro-1H-isoindol-2(3H)-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4,4a,8a-tetrahydroquinoline-3-carboxylic acid. Grades: > 95%. Molecular formula: C21H24FN3O4. Mole weight: 401.44. | |
| Moxifloxacin-R-isomer (ent-Moxifloxacin) | Cas No. 268545-13-7. | |
| Moxifloxacin RR-Isomer HCl | Moxifloxacin RR-Isomer HCl. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1394029-14-1. Molecular Formula: C21H25ClFN3O4. Mole Weight: 437.9. Catalog: APB1394029141. | |
| Moxifloxacin RR-Isomer (HCl salt form) | Cas No. 1394029-14-1. | |
| Moxifloxacin (Standard) | Moxifloxacin (Standard) is the analytical standard of Moxifloxacin. This product is intended for research and analytical applications. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia [1] [2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 151096-09-2. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-66011AR. |  |
| Moxilubant | Moxilubant (CGS-25019C;LTB-019) is an orally active BLT1 antagonist which inhibits LTB4 signaling with a potency of 2 - 4 nM. Moxilubant can be used for cancer research [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: CGS 25019C free base. CAS No. 146978-48-5. Pack Sizes: 5 mg; 10 mg. Product ID: HY-106929. | |
| Moxisylyte hydrochloride | Moxisylyte (hydrochloride) is (alpha 1-blocker) antagonist, it can vasodilates cerebral vessels without reducing blood pressure. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Thymoxamine hydrochloride. CAS No. 964-52-3. Pack Sizes: 10 mM * 1 mL; 25 mg; 50 mg; 100 mg. Product ID: HY-B1435. | |
| Moxisylyte hydrochloride | Moxisylyte hydrochloride is alpha 1-adrenoceptor antagonist. It can vasodilates cerebral vessels without reducing blood pressure. It is used as peripheral vasodilator. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine. It is used as sympathomimetic agents. It has been listed. Uses: Moxisylyte hydrochloride is used as peripheral vasodilator. it is also used as sympathomimetic agents. Synonyms: Carvacrol,5-[2-(dimethylamino)ethoxy]-, acetate (ester), hydrochloride (8CI);Phenol,4-[2-(dimethylamino)ethoxy]-2-methyl-5-(1-methylethyl)-, acetate (ester),hydrochloride (9CI);4-(2-Dimethylaminoethoxy)-5-isopropyl-2-methylphenyl acetatehydrochloride;Opilon hydrochloride; (2- (4-acetoxy-2-isopropyl-5-methylphenoxy) ethyl) dimethylaminehydrochloride; 5- (2- (N, N-dimethylamino) ethoxy) carvacrolacetatehydrochloride; Arlitene; Vasoklin; Moxisylyte HCl;[4-[2-(dimethylamino)ethoxy]-2-methyl-5-propan-2-ylphenyl] acetate;hydrochloride;Thymoxamine hydrochloride. Grades: >98 %. CAS No. 964-52-3. Molecular formula: C16H26ClNO3. Mole weight: 315.84. | |
| Moxonidine | Moxonidine is a selective agonist at the imidazoline receptor subtype (I1). It binds with much greater affinity to the imidazoline I1-receptor than to the α2-receptor while clonidine binds to both receptors with equal affinity. Uses: Antihypertensive agents. Synonyms: 4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine; 2-(6-Chloro-4-methoxy-2-methylpyrimidin-5-ylamino)-2-imidazoline; Lomox; Moxon; Norcynt; Normoxocin; Nucynt; Physiotens. Grades: >98%. CAS No. 75438-57-2. Molecular formula: C9H12ClN5O. Mole weight: 241.68. | |
| Moxonidine | Moxonidine is an antihypertensive agent. Group: Biochemicals. Alternative Names: 4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine; 2-(6-Chloro-4-methoxy-2-methylpyrimidin-5-ylamino)-2-imidazoline; Lomox; Moxon; Norcynt; Normoxocin; Nucynt; Physiotens. Grades: Highly Purified. CAS No. 75438-57-2. Pack Sizes: 25mg. US Biological Life Sciences. | Worldwide |
| Moxonidine | Moxonidine (BDF5895) is an imidazoline type 1 receptor (I1-R) selective agonist and antihypertensive agent. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BDF5895. CAS No. 75438-57-2. Pack Sizes: 10 mM * 1 mL; 100 mg. Product ID: HY-B0374. | |
| Moxonidine-D4 | Moxonidine-D4. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1794811-52-1. Molecular Formula: C9H8D4ClN5O. Mole Weight: 245.7. Catalog: APB1794811521. | |
| Moxonidine EP impurity B | Moxonidine EP impurity B. Uses: For analytical and research use. Group: Impurity standards. CAS No. 75439-01-9. Molecular Formula: C10H15N5O2. Mole Weight: 237.26. Catalog: APB75439019. | |
| Moxonidine EP impurity C | Moxonidine EP impurity C. Uses: For analytical and research use. Group: Impurity standards. CAS No. 352457-34-2. Molecular Formula: C9H13N5O2. Mole Weight: 223.24. Catalog: APB352457342. | |
| Moxonidine EP impurity D | Moxonidine EP impurity D. Uses: For analytical and research use. Group: Impurity standards. CAS No. 352457-33-1. Molecular Formula: C8H10ClN5O. Mole Weight: 227.65. Catalog: APB352457331. | |
| Moxonidine hydrochloride | Moxonidine hydrochloride is a mixed agonist of α2-adrenergic receptor (α2AR) and imidazoline-1 receptor(I1R). Its Ki values is 4.2±3.2 nmol/L, 13.0±4.2 nmol/L, 9.5±4.1 nmol/L and 15.6±9.8 nmol/L for I1R, α2AAR, α2BAR and α2CAR, respectively. It is used as antihypertensive agent. It displays 40-fold higher affinity for I1 receptors versus α2-adrenoceptors. It reduced stimulated NE overflow (log EC50: -6.15 +/- 0.14). It has been reported to produce dose-dependent analgesia in multiple acute pain assays and has been reported to potently inhibit the binding of [3H]-clonidine to VLM (ventrolateral medulla) membranes in a dose-dependent manner with the IC50 value of 53 ± 10nM. It has shown low affinity for I2-relative to I1R sites in bovine adrenal medullary cells. Uses: Moxonidine hydrochloride is used as antihypertensive agent. it has been reported to produce dose-dependent analgesia in multiple acute pain assays and has been reported to potently inhibit the binding of [3h]-clonidine to vlm (ventrolateral medulla) membranes in a dose-dependent manner with the ic50 value of 53 ± 10nm. Synonyms: BDF5895 hydrochloride; BDF 5895 hydrochloride; BDF-5895 hydrochloride; 4-Chloro-6-methoxy-2-methyl-5-(2-imidazolin-2-yl)aminopyrimidine hydrochloride. Grades: 98%. CAS No. 75536-04-8. Molecular formula: C9H13Cl2N5O. Mole weight: 278.14. | |
| Moxonidine hydrochloride | Moxonidine hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 75536-04-8. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| Moxonidine hydrochloride | Moxonidine Hydrochloride is a selective agonist at the imidazoline receptor subtype 1, used as antihypertensive agent. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BDF5895 hydrochloride. CAS No. 75536-04-8. Pack Sizes: 10 mM * 1 mL; 5 mg. Product ID: HY-B0374A. | |
| Moxonidine impurity 2 | Moxonidine impurity 2. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C9H10ClN7O3. Mole Weight: 299.68. Catalog: APB08677. | |
| Moxonidine impurity 3 | Moxonidine impurity 3. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C9H11ClN6O2. Mole Weight: 270.68. Catalog: APB08678. | |
| Moxonidine impurity 4 | Moxonidine impurity 4. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C9H10ClN7O3. Mole Weight: 299.68. Catalog: APB08679. | |
| Moxonidine Impurity A | An impurity of Moxonidine, which is a selective agonist at the imidazoline receptor subtype (I3). Synonyms: 4,6-dichloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2-methylpyrimidin-5-amine. Grades: > 95%. CAS No. 352457-35-3. Molecular formula: C8H9Cl2N5. Mole weight: 246.1. | |
| Moxonidine Impurity B | An impurity of Moxonidine, which is a selective agonist at the imidazoline receptor subtype (I1). Synonyms: 4-Methoxy Moxonidine; N-(4,5-Dihydro-1H-imidazol-2-yl)-4,6-dimethoxy-2-methyl-5-pyrimidinamine. Grades: > 95%. CAS No. 75439-01-9. Molecular formula: C10H15N5O2. Mole weight: 237.26. | |
| Moxonidine Impurity C | An impurity of Moxonidine, which is a selective agonist at the imidazoline receptor subtype (I2). Synonyms: 4-Hydroxymoxonidine; 5-[(4,5-Dihydro-1H-imidazol-2-yl)amino]-6-methoxy-2-methyl-4(3H)-pyrimidinone; 5-[(4,5-Dihydro-1H-imidazol-2-yl)amino]-6-methoxy-2-methyl-4(1H)-pyrimidinone. Grades: > 95%. CAS No. 352457-34-2. Molecular formula: C9H13N5O2. Mole weight: 223.24. | |
| Moxonidine Impurity D | An impurity of Moxonidine, which is a selective agonist at the imidazoline receptor subtype (I1). Synonyms: 6-Chloro-5-[(4,5-dihydro-1H-imidazol-2-yl)amino]-2-methyl-4(1H)-pyrimidinone; 6-Desmethyl Moxonidine. Grades: > 95%. CAS No. 352457-33-1. Molecular formula: C8H10ClN5O. Mole weight: 227.65. | |
| Mozavaptan | Mozavaptan (OPC-31260) inhibits AVP binding to V1 and V2 receptors in a competitive manner. Uses: Antidiuretic hormone receptor antagonists. Synonyms: N-(4-(5-(dimethylamino)-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)phenyl)-2-methylbenzamide; OPC-31260; OPC 31260; OPC31260; Mozavaptan. Grades: >98%. CAS No. 137975-06-5. Molecular formula: C27H29N3O2. Mole weight: 427.54. | |
| MOZ-IN-3 | MOZ-IN-3 is a highly potent and selective inhibitor of lysine acetyltransferase 6A (KAT6A/MOZ) with IC50 value of 8 nM. It also inhibits KAT6B/MORF with IC50 value of 28 nM. MOZ-IN-3 induced cell cycle arrest in and inhibited proliferation of mouse embryonic fibroblasts (IC50 = 2.4 μM), and induced cellular senescence without causing DNA damage or displaying a general cytotoxicity effect in mouse lymphoma cells. Synonyms: WM-8014; WM 8014; WM8014; 4-fluoro-5-methyl-N'-(phenylsulfonyl)[1,1'-biphenyl]-3-carbohydrazide. Grades: ≥98%. CAS No. 2055397-18-5. Molecular formula: C20H17FN2O3S. Mole weight: 384.43. | |
| MP7 | MP7 (PDK1 inhibitor) is a phosphoinositide-dependent kinase-1 ( PDK1 ) inhibitor. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PDK1 inhibitor. CAS No. 1001409-50-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-14440. | |
| MP-A08 | MP-A08 is a cell permeable selective inhibitor of sphingosine kinase 2 (Ki=6.9 μM) and 1 (Ki=27 μM) with little affinity for other kinases. In vitro: inhibits cellular S1P production and increases sphingosine and ceramide levels. Synonyms: MP-A08; MP A08; MPA08; NSC-122314; NSC 122314; NSC122314; 4- methyl -N- [2- [ [2- [ (4-methyl phenyl ) sulfonyl amino] ph enyl ] imino methyl ] phenyl ] Ben zene sulfonamide MP-A08NSC122314AC1L9JETAmbcb5562335SCHE MBL17443540MCULE-6662772127N- [2- [ [2-(Tosyl amino) benzyl ide ne ] amino ] phenyl ]-4- methyl Benzene sulfonamide MP A08|NSC 1223. CAS No. 219832-49-2. Molecular formula: C27H25N3O4S2. Mole weight: 519.64. | |
| MPBP | Heterocyclic Organic Compound. CAS No. 12578-81-9. Catalog: ACM12578819. |  |
| MPC-0767 | MPC-0767 is a novel L-alanine ester pro-drug of MPC-3100, designed to have improved aqueous solubility compared to MPC-3100. Synonyms: MPC-0767; MPC 0767; MPC0767. Grades: >98%. CAS No. 1310540-32-9. Molecular formula: C26H36BrN7O9S2. Mole weight: 733.64. | |
| MPC-3100 | MPC-3100 targets the N-terminal ATP-binding site of Hsp90 and blocks the activity of ATPase. In the Her2-luciferase degradation assay, MPC-3100 reduces this client protein of Hsp90 with IC50 value of 60nM. In HCT-116 cell lines, MPC-3100 inhibits cell proliferation with IC50 value of 540 nM. Besides that, MPC-3100 shows a broad spectrum anti-proliferative activity against various cancer cell lines, such as NCI-N87 and DU-145. MPC-3100 also inhibits tumor growth in the NCI-N87 gastric cancer xenograft mode. Moreover, PK studies show that MPC-3100 displays a superior oral PK profile, good overall exposure and a reasonable hepatic clearance rate. Phase I clinical studies demonstrate MPC-3100 is safe and tolerated when administered at doses below 600 mg per day. Synonyms: MPC-3100; MPC 3100; MPC3100. Grades: >98%. CAS No. 958025-66-6. Molecular formula: C22H25BrN6O4S. Mole weight: 549.40. | |
| MPC-3100 | MPC-3100 is a recently discovered fully synthetic purine-based Hsp90 Inhibitor exhibiting anticancer properties. Group: Biochemicals. Alternative Names: (2S)-1-[4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl]ethyl]-1-piperidinyl]-2-hydroxy-1-propanone. Grades: Highly Purified. CAS No. 958025-66-6. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| MPC 6827 hydrochloride | MPC 6827 hydrochloride, the hydrochloride salt form of verubulin, inhibits of microtubule formation (IC50 = 1.5 - 3.4 nM). in vitro: inhibits polymerization of tubulin in vivo: inhibits tumor growth. Synonyms: N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine; hydrochloride; MPC-6827; MPC6827; N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine; verubulin; verubulin hydrochloride; Azixa; MPC-6827; UNII-33380QZ0QW; 917369-31-4. CAS No. 917369-31-4. Molecular formula: C17H17N3O.HCl. Mole weight: 315.8. | |
| MPC 6827 hydrochloride | MPC 6827 hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 917369-31-4. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| MPDC | MPDC. Group: Biochemicals. Grades: Purified. CAS No. 159262-32-5. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| MPDC | MPDC is a potent inhibitor of the Na+-dependent high-affinity synaptosomal glutamate transporter and may be useful in the treatment of neurodegeneration. Synonyms: L-anti-endo-3,4-Methanopyrrolidinedicarboxylic acid. CAS No. 159262-32-5. Molecular formula: C7H9NO4. Mole weight: 171.15. | |
| MPDL3280A | A human, Fc optimized, monoclonal antibody directed against the protein ligand PD-L1 (programmed cell death-1 ligand 1), with potential immune checkpoint inhibitory and antineoplastic activities. Atezolizumab binds to PD-L1, blocking its binding to and activation of its receptor programmed death 1 (PD-1) expressed on activated T-cells, which may enhance the T-cell-mediated immune response to neoplasms and reverse T-cell inactivation. In addition, by binding to PD-L1, atezolizumab also prevents binding of this ligand to B7.1 expressed on activated T cells, which further enhances the T-cell-mediated immune response. PD-L1 is overexpressed on many human cancer cell types and on various tumor-infiltrating immune cells. PD-L1 binding to PD-1 on T-cells suppresses the immune system and results in increased immune evasion. PD-1, a transmembrane protein, is a negative regulator of the immune system that limits the expansion and survival of CD8+ T cells. The Fc region of atezolizumab is modified in such a way that it does not induce either antibody-dependent cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC). Synonyms: Atezolizumab; RG 7446; RO 5541267; RG7446; RO5541267; RG-7446; RO-5541267; TECENTRIQ. CAS No. 1380723-44-3. Molecular formula: C37H62N4O2S. Mole weight: 627. | |
| mPEG10K-Propionaldehyde | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Propionaldehyde, mPEG-ALD, Methoxy-PEG-Propionaldehyde. Molecular formula: average Mn 10000. |  |
| mPEG10K-Succinimidyl Carboxymethyl Ester | Methoxy PEG NHS Ester (SCM PEG). Amine reactive PEG towards the amino groups of lysine(s) on proteins or other biologics; reaction occurs at room temperature in <1hr at pH 7-8. Stable linker between PEG and NHS ester. Uses: S may include: bioconjugation, drug delivery, peg hydrogel, crosslinker, and surface functionalization. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 10000. | |
| m-PEG10-SH | m-PEG10-SH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Group: Functional pegs. Alternative Names: 2,5,8,11,14,17,20,23,26,29-Decaoxahentriacontane-31-thiol. CAS No. 651042-85-2. Molecular formula: C21H44O10S. Mole weight: 488.6. Appearance: Liquid. Purity: >90%. IUPACName: 2- [2- [2- [2- [2- [2- [2- [2- [2- (2-Methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanethiol. Canonical SMILES: COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCS. Density: 1.079 g/cm3. Catalog: ACM651042852-1. | |
| m-PEG12-acid | m-PEG12-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2135793-73-4. Pack Sizes: 50 mg; 100 mg; 250 mg. Product ID: HY-135820. | |
| mPEG12-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| m-PEG12-amine | m-PEG12-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs [1]. m-PEG12-amine is also a non-cleavable 12 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) [2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1977493-48-3. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-140227. | |
| mPEG12-Azide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 12000. | |
| mPEG12-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanamine. Molecular formula: 559.7g/mol. Mole weight: C25H53NO12. COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC CN. InChI= 1S / C25H53NO12 / c1-27-4-5-29-8-9-31-12-13-33-16-17-35 -20-21-37-24-25-38-23-22-36-19-18-34- 15-14-32-11-10-30-7-6-28-3-2-26 / h2-26H | |
| mPEG12-OH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Methoxy-PEG12-Hydroxyl. Product ID: 2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanol. Molecular formula: 560.7g/mol. Mole weight: C25H52O13. [H]OCCOC. 1S/C3H8O2/c1-5-3-2-4/h4H,2-3H2,1H3. XNWFRZJHXBZDAG-UHFFFAOYSA-N. | |
| mPEG12-Propionic acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG12-PA, methoxy-PEG-Propionic acid. OC(CCOCCOC)=O. 1S/C6H12O4/c1-9-4-5-10-3-2-6 (7)8/h2-5H2, 1H3, (H, 7, 8). KWMXBFIAGYXCCC-UHFFFAOYSA-N. | |
| mPEG12-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanethiol. Molecular formula: 576.7g/mol. Mole weight: C25H52O12S. COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC CS. InChI= 1S / C25H52O12S / c1-26-2-3-27-4-5-28-6-7-29-8-9-30-10- 11-31-12-13-32-14-15-33-16-17-34-18-1 9-35-20-21-36-22-23-37-24-25-38 / h38H, | |
| mPEG16-NH2 | mPEG16-NH2. Group: Polymers. CAS No. 907577-50-8. Product ID: 2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanamine. Molecular formula: 735.9g/mol. Mole weight: C33H69NO16. COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC COCCOCCOCCOCCN. InChI= 1S / C33H69NO16 / c1-35-4-5-37-8-9-39-12-13-41-16-17-43 -20-21-45-24-25-47-28-29-49-32-33-50- 31-30-48-27-26-46-23-22-44-19-18-42-1 5-14-40-11-10-38-7-6-36-3-2-34 / h2-34H2, 1H3. AZTFEVBTZHBNCX-UHFFFAOYSA-N. | |
| mPEG2000C-DMG | Synonyms: α - (3'-{[1, 2-di (myristyloxy) propanoxy]carbonylamino}propyl) -ω -methoxy, polyoxyethylene. Grades: >97%. CAS No. 1019000-64-6. Molecular formula: (C2H4O)nC36H73NO5. | |
| MPEG-2000-DSPE | MPEG-2000-DSPE was used to study stability and biodistribution and toxicity of lung-specific liposomal antitubercular drugs. Group: Biochemicals. Grades: Highly Purified. CAS No. 147867-65-0. Pack Sizes: 100mg, 250mg. Molecular Formula: (C2H4O)nC43H84NO10P. US Biological Life Sciences. | Worldwide |
| mPEG20K-MAL | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-MAL, Methoxy-PEG-Maleimide. Molecular formula: average Mn 20000. | |
| mPEG20K-Silane | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 20000. | |
| mPEG20K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 20000. | |
| mPEG2K-MAL | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-MAL, Methoxy-PEG-Maleimide. Molecular formula: average Mn 2000. | |
| mPEG2k-PLA2k-PAE9k | mPEG2k-PLA2k-PAE9k. Synonyms: methoxy polyethylene glycol-Poly(D,L-lactide)-Poly(b-amino esters). Product ID: MSMN-057. Category: Raw Materials. |  |
| mPEG2K-Thioctic acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 2000. | |
| mPEG30K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 30000. | |
| MPEG ~350 (Methoxypolyethylene Glycol) | Methoxypolyethylene Glycol of with an average molecular mass of 350. Methoxypolyethylene Glycol (MPEG) is used in various applications such as micelles for drug delivery as well as in modifications of therapeutic proteins to improve their pharmacokinetics. Group: Biochemicals. Grades: Highly Purified. CAS No. 9004-74-4. Pack Sizes: 50g, 100g. Molecular Formula: CH3O(CH2CH2O)nH, Molecular Weight: US Biological Life Sciences. | Worldwide |
| mPEG40K-MAL | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-MAL, Methoxy-PEG-Maleimide. Molecular formula: average Mn 40000. | |
| mPEG40K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 40000. | |
Our database is helping our users find suppliers everyday.
